Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2002 Apr;53(4):408-9.
doi: 10.1046/j.1365-2125.2002.01572_6.x.

CYP2C9 polymorphism and warfarin dose requirements

Ann K Daly, Christopher P Day, Guruprasad P Aithal
Comment

CYP2C9 polymorphism and warfarin dose requirements

Ann K Daly et al. Br J Clin Pharmacol. 2002 Apr.
No abstract available

PubMed Disclaimer

Comment on

References

    1. Goldstein JA. Clinical relevance of genetic polymorphisms in the human CYP2C subfamily. Br J Clin Pharmacol. 2001;52:349–355. 10.1046/j.0306-5251.2001.01499.x. - DOI - PMC - PubMed
    1. Aithal GP, Day CP, Kesteven PJL, Daly AK. Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications. Lancet. 1999;353:717–719. - PubMed
    1. Yasar U, Eliasson E, Dahl ML, Johansson I, Ingelman-Sundberg M, Sjoqvist F. Validation of methods for CYP2C9 genotyping: Frequencies of mutant alleles in a Swedish population. Biochem Biophys Res Comm. 1999;254:628–631. - PubMed
    1. Wang S-L, Huang J-D, Lai M-D, Tsai J-J. Detection of CYP2C9 polymorphism based on the polymerase chain reaction in Chinese. Pharmacogenetics. 1995;5:37–42. - PubMed
    1. Taube J, Halsall D, Baglin T. Influence of cytochrome P-450CYP2C9 polymorphisms on warfarin sensitivity and risk of over-anticoagulation in patients on long-term treatment. Blood. 2000;96:1816–1819. - PubMed

MeSH terms